RSV-001 (Aegis Life)

N/A

Report date: 2022/01/05 10:23:57

Base Information

Drug NameRSV-001 (Aegis Life)
Drug Alias NameRSV001 (Aegis Life)RSV nAbs (Aegis Life)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunomodulatorsRNA modulators
TargetsRibonucleic Acid
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAegis Life Inc
China Registration ClassN/A

Develop Information

Active CompaniesAegis Life Inc
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A